the last week in june, page-15

ANP is running a tight ship. Other than the 3B 'heads up', there isn't any 'leak' I can remember from SP action pre ann.

Here are what we know:

The last update did announce that the DD of the big pharma will conclude end of this month. So we should know which Pharma it was and what the intention is going forward.

We know Afandin's option is due soon. (further extension is still possible).

In was also announced that the TJAB agreement will be finalised before end of July. (I suspect that ANP is leaving the doors open to see what the big Pharma could come up with before finalising with TJAB.)

We know that we have fund for Phase 2 trial and it is in progress.



There will be plenty of news flow from this week onwards.

If they are all good, we could see the SP move back to where it should be.